Revive Therapeutics Ltd (RVVTF)

$0.02 0.00 (-1.00%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 404,991
Avg Vol 703,312
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 0%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which i...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 888-901-0036
Fax: 905-248-3355
Address:
The Canadian Venture Building, 82 Richmond Street East, Toronto, Canada
Barron401k
Barron401k May. 13 at 6:32 PM
$RVVTF The duration of silence correlates to the size of the prize... Patience will pay off on this one. I may move money around just to pounce harder.
0 · Reply
BeforeTheRobots
BeforeTheRobots May. 13 at 5:57 PM
$RVVTF I really thought I was done adding here, but if it stays below .02 for long I may reconsider
0 · Reply
BobWarner99
BobWarner99 May. 13 at 4:58 PM
$RVVTF 🤔😉😎 https://www.youtube.com/watch?v=gzOeAXrgYBI&list=RDgzOeAXrgYBI&start_radio=1
0 · Reply
SUPERKKING
SUPERKKING May. 13 at 4:05 PM
$RVVTF our time will come soon 🤑
2 · Reply
BobWarner99
BobWarner99 May. 13 at 3:49 PM
$RVVTF At least for as developments(updates) in the Press Release we're in the End Game. Will the wait have been well worth it? We'll see.....
0 · Reply
Tartufo
Tartufo May. 13 at 2:24 PM
$RVVTF This was having a nice run a few weeks ago, now quite the opposite but I am still holding on to this lottery ticket. GLTA
1 · Reply
Canadianbull1324
Canadianbull1324 May. 12 at 4:12 PM
$RVVTF ok it's been 2 months since PR. The study is complete. Wednesdays are news days. I'm hoping that means tomorrow is our day!
0 · Reply
Canadianbull1324
Canadianbull1324 May. 12 at 3:29 PM
$RVVTFRESEARCH and development of Bucillamine is strongly warranted.
0 · Reply
Bulldog_Retired
Bulldog_Retired May. 12 at 12:15 PM
$RVVTF “The ongoing research into Bucillamine as a treatment for nerve agent exposure is highly promising. Its potent antioxidant properties and its ability to replenish glutathione through multiple mechanisms, including the activation of the Nrf2 pathway, position it as a strong candidate for mitigating the secondary neuronal damage that is a major contributor to the long- term morbidity of nerve agent poisoning.” https://pdf.benchchem.com/1668/Bucillamine_as_a_Novel_Countermeasure_for_Nerve_Agent_Exposure_A_Technical_Whitepaper.pdf
0 · Reply
Tbickle
Tbickle May. 11 at 7:38 PM
$RVVTF
1 · Reply
Latest News on RVVTF
No data available.
Barron401k
Barron401k May. 13 at 6:32 PM
$RVVTF The duration of silence correlates to the size of the prize... Patience will pay off on this one. I may move money around just to pounce harder.
0 · Reply
BeforeTheRobots
BeforeTheRobots May. 13 at 5:57 PM
$RVVTF I really thought I was done adding here, but if it stays below .02 for long I may reconsider
0 · Reply
BobWarner99
BobWarner99 May. 13 at 4:58 PM
$RVVTF 🤔😉😎 https://www.youtube.com/watch?v=gzOeAXrgYBI&list=RDgzOeAXrgYBI&start_radio=1
0 · Reply
SUPERKKING
SUPERKKING May. 13 at 4:05 PM
$RVVTF our time will come soon 🤑
2 · Reply
BobWarner99
BobWarner99 May. 13 at 3:49 PM
$RVVTF At least for as developments(updates) in the Press Release we're in the End Game. Will the wait have been well worth it? We'll see.....
0 · Reply
Tartufo
Tartufo May. 13 at 2:24 PM
$RVVTF This was having a nice run a few weeks ago, now quite the opposite but I am still holding on to this lottery ticket. GLTA
1 · Reply
Canadianbull1324
Canadianbull1324 May. 12 at 4:12 PM
$RVVTF ok it's been 2 months since PR. The study is complete. Wednesdays are news days. I'm hoping that means tomorrow is our day!
0 · Reply
Canadianbull1324
Canadianbull1324 May. 12 at 3:29 PM
$RVVTFRESEARCH and development of Bucillamine is strongly warranted.
0 · Reply
Bulldog_Retired
Bulldog_Retired May. 12 at 12:15 PM
$RVVTF “The ongoing research into Bucillamine as a treatment for nerve agent exposure is highly promising. Its potent antioxidant properties and its ability to replenish glutathione through multiple mechanisms, including the activation of the Nrf2 pathway, position it as a strong candidate for mitigating the secondary neuronal damage that is a major contributor to the long- term morbidity of nerve agent poisoning.” https://pdf.benchchem.com/1668/Bucillamine_as_a_Novel_Countermeasure_for_Nerve_Agent_Exposure_A_Technical_Whitepaper.pdf
0 · Reply
Tbickle
Tbickle May. 11 at 7:38 PM
$RVVTF
1 · Reply
Canadianbull1324
Canadianbull1324 May. 11 at 6:47 PM
$RVVTF what's the percentage chance the DRDC shows positive results? Drop your percentage in replies
6 · Reply
Barron401k
Barron401k May. 8 at 6:10 PM
$RVVTF fyi... Here's the Canadian version of the federal register. Sorry. It's not much but... https://canadabuys.canada.ca/en/tender-opportunities
1 · Reply
Canadianbull1324
Canadianbull1324 May. 8 at 1:26 PM
$RVVTF historically they drop news around 7-730am... If there's no press by then the day is pooched. This is going to dwindle slowly without news.
1 · Reply
Barron401k
Barron401k May. 7 at 8:40 PM
$RVVTF 🚨🚨🚨 Could Bucillamine help with Hantavirus?? MF should POUNCE on the possibility! While there is no documented direct relationship or targeted research, Bucillamine’s profile as a thiol antioxidant suggests hypothetical supportive potential in oxidative stress-heavy viral infections like hantavirus pulmonary syndrome (HPS/HCPS) or hemorrhagic fever with renal syndrome (HFRS), similar to broader interest in NAC/thiols. Worth a patent/PR if he can figure out how to say "while early, we are looking into the possibility that buccilamine *may* prove of some use in hantavirus cases..." Ok. Let the scientists weigh in. Lol
2 · Reply
Tartufo
Tartufo May. 7 at 7:52 PM
$RVVTF when moon?
0 · Reply
Mitchz11
Mitchz11 May. 7 at 3:04 PM
$RVVTF I am hoping news will be sooner then later. In the press release in December it said they should be concluding the trial end of January. I believe MF has the self control to keep quiet for a few months if he knew big news is coming. He would break if the DRDC said the trial was unsuccessful or if they are not releasing results for while. Keep the faith!
0 · Reply
Canadianbull1324
Canadianbull1324 May. 7 at 2:27 PM
$RVVTF we started suddenly gaining in the days before the news release... After months of being flat.
0 · Reply
T3hDave
T3hDave May. 6 at 3:57 PM
$RVVTF anon buying .025 selling .035 on the CAD ATS, slow accumulation again
1 · Reply
Canadianbull1324
Canadianbull1324 May. 5 at 12:44 PM
$RVVTF everyone is talking about 1 year to the ath but remember, this would be fast tracked. If a fast track leads to stockpiling, this could sky rocket within a few months
3 · Reply
Bulldog_Retired
Bulldog_Retired May. 4 at 9:26 PM
$RVVTF Psilocybin study that I hadn't seen before: "Psilocybin microdosing in the United States: Insights from a nationally representative survey" https://onlinelibrary.wiley.com/doi/10.1111/add.70368
0 · Reply
Lessworkmorefunds
Lessworkmorefunds May. 4 at 6:42 PM
$RVVTF What are all y’all’s price targets for RVV, assuming we show efficacy in the DRDC trial?
4 · Reply
T3hDave
T3hDave May. 4 at 5:53 PM
$RVVTF decent volume today on the canadian side (CSE retail) ATS ( more institutionalish)
1 · Reply